InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa
INNVInnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa
Innoviz Reports Second Quarter 2025 Results
INNVRecord H1 revenues exceed full-year 2024 levels; Q2 cash burn[1] at ~$7.3M; reiterating 2025 revenue guidance; raising NRE bookings targets Development agreement with Top 5 passenger OEM reinforces Innoviz's position as a preferred technology partner for global OEMs Supporting increasing...
InnovAge Holding Affirms FY2025 Sales Guidance of $815.00M-$865.00M vs $847.78M Est
INNVInnovAge Holding Q3 EPS $(0.08) Misses $(0.01) Estimate, Sales $218.14M Beat $214.09M Estimate
INNVInnovAge Holding Affirms FY2025 Sales Guidance to $815.00M-865.00M VS Est. 844.27M
INNVInnovAge Holding Q1 EPS $(0.04), Inline, Sales $205.14M Beat $203.33M Estimate
INNVInsights Ahead: InnovAge Holding's Quarterly Earnings
INNVInnovAge Appoints Michael Scarbrough As New President And Chief Operating Officer And Maria Lozzano as President, Pharmacy Services, Effective November 4th.
INNVInnovAge Holding Q4 EPS $(0.09) Misses $(0.03) Estimate, Sales $172.86M Miss $173.81M Estimate
INNVInnovAge Holding's Earnings Outlook
INNVInnovAge Holding (NASDAQ:INNV) is set to give its latest quarterly earnings report on Tuesday, 2022-09-13. Here's what investors need to know before the announcement.
Analysts estimate that InnovAge Holding will report an earnings per share (EPS) of $-0.03.